NMAD$3.45-0.58%
Nomad Power Solutions, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$65.87M
Float & O/S:
Inst Own:
DilutionScan read 31 of NOMAD POWER SOLUTIONS, INC.'s SEC filings and found 15 warrant series, 3 convertibles, 1 ATM program, 2 shelf registrations, 2 S-1 registrations and 3 completed offerings on file for NMAD. Analysis updated Oct 13, 2026.
Signal8 Summary
NMAD
Pre-revenue shell mid-pivot, heavy dilution
Snapshot
NOMAD Power Solutions is a company in transition: what was Lixte Biotechnology, a clinical-stage drugmaker, has become a battery energy storage business, but the financials still reflect the old, pre-revenue company.
What's Happening Right Now
- : NOMAD adjourned its Special Meeting of Stockholders on Sept 4, 2026 without conducting business, pushing it to Oct 2, 2026 to give the company more time to finalize its Nasdaq listing application.
- : NOMAD received DOE authorization to move its roughly $19 million Vermont long-duration energy storage project into Phase 3 installation, with a $9.5 million DOE cost-share award backing deployment across five Green Mountain Power sites.
- : NOMAD's 1 MW Traveler battery storage system achieved UL 9540 certification and was delivered to a First Nation community in Northern Ontario for resilient power deployment.
- : NOMAD (formerly Lixte Biotechnology) filed its Q2 2026 10-Q detailing a corporate name change, acquisition of an AI energy infrastructure business, a new board member, and new subsidiary leadership as it transitions to battery storage.
- : DSO Electric Cooperative put two NOMAD Traveler battery systems into ongoing seasonal operation after a 2025 pilot projected over $100,000 in seasonal demand cost savings.
